Share This Page
Drug Price Trends for ANTACID-ANTIGAS
✉ Email this page to a colleague

Average Pharmacy Cost for ANTACID-ANTIGAS
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ANTACID-ANTIGAS SUSPENSION | 46122-0434-40 | 0.01055 | ML | 2025-01-22 |
ANTACID-ANTIGAS LIQUID | 70000-0063-01 | 0.01055 | ML | 2025-01-22 |
ANTACID-ANTIGAS LIQUID | 00536-1293-83 | 0.01055 | ML | 2025-01-22 |
ANTACID-ANTIGAS LIQUID | 00536-1317-83 | 0.01055 | ML | 2025-01-22 |
ANTACID-ANTIGAS LIQUID | 70000-0063-01 | 0.01068 | ML | 2024-12-18 |
ANTACID-ANTIGAS LIQUID | 00536-1293-83 | 0.01068 | ML | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Antacids Market Analysis and Price Projections: A Comprehensive Overview
Introduction to the Antacids Market
The antacids market is a significant segment within the pharmaceutical industry, driven by the increasing prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD), heartburn, and indigestion. Here, we will delve into the market analysis, growth projections, and key factors influencing the antacids market, particularly focusing on the drug category that includes antacids like ANTACID-ANTIGAS.
Market Size and Growth Projections
The global antacids market is anticipated to experience substantial growth over the next few years. Here are some key projections:
- The market size was valued at approximately USD 6,810.11 million in 2023 and is expected to grow to USD 8,194.33 million by 2028, with a Compound Annual Growth Rate (CAGR) of 3.7%[1].
- Another forecast indicates that the market size was USD 7.63 billion in 2023 and is projected to reach USD 10.39 billion by 2030, growing at a CAGR of 4.5%[2].
- A more aggressive growth projection suggests the market will reach USD 9,756.34 million by 2030, with a CAGR of 5.2% from 2023 to 2030[4].
Impact of COVID-19 on the Antacids Market
The COVID-19 pandemic had a dual impact on the antacids market. Initially, production and supply chain disruptions led to higher prices and reduced availability. However, the pandemic also highlighted the importance of antacids in managing acidosis in COVID-19 patients, which boosted demand and revenue.
"Acidosis-related pH promoted SARS-CoV-2 infection and suggested the existence of a positive feedback loop in which SARS-CoV-2 infection-induced acidosis enhances SARS-CoV-2 infection. Therefore, antacid therapy for acidosis COVID-19 patients was necessary during the pandemic."[1]
Segmentation of the Antacids Market
The antacids market is segmented based on several criteria:
By Dosage Form
- Tablets
- Liquid
- Powder
- Others[2][4]
By Drug Class
- Proton Pump Inhibitors (PPIs)
- H2 Antagonists
- Acid Neutralizers
- Pro-Motility Agents[2]
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy[2][4]
By Type
- Sodium Antacids
- Calcium Antacids
- Magnesium Antacids
- Aluminium Antacids
- Others[4]
Key Drivers of Market Growth
Several factors are driving the growth of the antacids market:
Increasing Prevalence of Gastrointestinal Disorders
The rise in GERD, heartburn, and indigestion cases, partly due to changing lifestyles such as unstable eating patterns, sedentary lifestyles, and irregular sleep patterns, is a significant driver[5].
Product Advancements
The development of safe and effective raft-forming antacids with longer durations of action and higher efficacy is boosting market expansion[5].
Affordability and Accessibility
Antacids are widely used due to their affordability and ease of access through various distribution channels[5].
Market Size Estimation Techniques
For new pharmaceutical drugs like antacids, market size estimation involves several approaches:
Bottom-Up Market Analysis
This involves estimating the potential market size by considering factors such as total population, incidence and prevalence of the disease, addressable market size, percentage of diagnosed patients, treatment rates, and pricing studies[3].
Analyst Insights and Research Reports
Cross-checking market estimation results with external reports and similar product revenues helps in refining the estimates[3].
Segmentation Analysis
Identifying different customer segments, such as severely, moderately, and mildly affected patients, helps in refining penetration and share forecasts[3].
Regional Market Analysis
The United States holds a significant share of the global antacids market, accounting for around 28.1% of the global market. This region is projected to continue its profitable growth trajectory[5].
Price Projections and Revenue Forecasting
Given the various growth projections, here are some insights into price and revenue forecasting:
- The market is expected to grow from USD 6,971.2 million in 2023 to USD 11,194.8 million by 2033, with a CAGR of 4.9%[5].
- The average price per unit of antacids can be influenced by factors such as production costs, regulatory environments, and competitive pricing strategies.
Competitive Landscape
The antacids market is competitive, with several major players. The dominance of certain types of antacids, such as sodium antacids, is due to high demand and efficacy[4].
Regulatory Framework and Patient Epidemiology
Understanding the regulatory framework and patient epidemiology is crucial for market forecasting. This includes analyzing the impact of regulatory changes, patient demographics, and disease prevalence on market dynamics[4].
Conclusion
The antacids market is poised for significant growth driven by increasing gastrointestinal disorders, product advancements, and changing lifestyles. Understanding the market segmentation, drivers, and estimation techniques is essential for businesses looking to capitalize on this trend.
Key Takeaways
- The global antacids market is expected to grow significantly over the next few years, with CAGRs ranging from 3.7% to 5.2%.
- The COVID-19 pandemic highlighted the importance of antacids in managing acidosis.
- Market segmentation includes dosage forms, drug classes, distribution channels, and types of antacids.
- Key drivers include the increasing prevalence of gastrointestinal disorders and product advancements.
- Regional markets, such as the United States, are significant contributors to global growth.
FAQs
What is the expected growth rate of the antacids market?
The antacids market is expected to grow at a CAGR ranging from 3.7% to 5.2% over the forecast period[1][2][4].
How did the COVID-19 pandemic impact the antacids market?
The pandemic initially disrupted production and supply chains but later boosted demand due to the need for antacid therapy in COVID-19 patients[1].
What are the main drivers of the antacids market growth?
Key drivers include the increasing prevalence of gastrointestinal disorders, product advancements, and changing lifestyles[5].
Which region holds a significant share of the global antacids market?
The United States holds around 28.1% of the global antacids market and is projected for continued growth[5].
What are the common types of antacids in the market?
Common types include sodium antacids, calcium antacids, magnesium antacids, and aluminium antacids[4].
Sources
- Mordor Intelligence: Antacids Market Report | Industry Analysis, Size & Forecast Overview
- Maximize Market Research: Antacids Market - Global Industry Analysis and Forecast (2024-2030)
- iHealthcare Analyst: Revenue Forecasting Techniques for New Pharmaceutical Drugs
- Data Bridge Market Research: Global Antacids Market – Industry Trends and Forecast to 2030
- GlobeNewswire: Antacids Market Growth Accelerating with Consumption of High Cholesterol Food and Rise in the Prevalence of Heartburn and GERD - Future Market Insights Inc.
More… ↓